학술논문

Novel Genetic Variants Associated With Increased Vertebral Volumetric BMD, Reduced Vertebral Fracture Risk, and Increased Expression of SLC1A3 and EPHB2
Document Type
article
Source
Journal of Bone and Mineral Research. 31(12)
Subject
Biological Sciences
Biomedical and Clinical Sciences
Clinical Sciences
Genetics
Human Genome
Aging
Osteoporosis
Biomedical Imaging
Aetiology
2.1 Biological and endogenous factors
Musculoskeletal
Animals
Biopsy
Bone Density
Cancellous Bone
Excitatory Amino Acid Transporter 1
Gene Expression Regulation
Genetic Association Studies
Genetic Predisposition to Disease
Humans
Linkage Disequilibrium
Lumbar Vertebrae
Mice
Molecular Sequence Annotation
Organ Size
Osteoblasts
Polymorphism
Single Nucleotide
Quantitative Trait Loci
Receptor
EphB2
Risk Factors
Spinal Fractures
Spine
BONE QCT
CT
ANALYSIS
QUANTITATION OF BONE
OSTEOPOROSIS
DISEASES AND DISORDERS OF
RELATED TO BONE
GENERAL POPULATION STUDIES
EPIDEMIOLOGY
HUMAN ASSOCIATION STUDIES
GENETIC RESEARCH
FRACTURE RISK ASSESSMENT
ANALYSIS/QUANTITATION OF BONE
BONE QCT/μCT
DISEASES AND DISORDERS OF/RELATED TO BONE
EPIDEMIOLOGY
HUMAN ASSOCIATION STUDIES
Engineering
Medical and Health Sciences
Anatomy & Morphology
Biological sciences
Biomedical and clinical sciences
Language
Abstract
Genome-wide association studies (GWASs) have revealed numerous loci for areal bone mineral density (aBMD). We completed the first GWAS meta-analysis (n = 15,275) of lumbar spine volumetric BMD (vBMD) measured by quantitative computed tomography (QCT), allowing for examination of the trabecular bone compartment. SNPs that were significantly associated with vBMD were also examined in two GWAS meta-analyses to determine associations with morphometric vertebral fracture (n = 21,701) and clinical vertebral fracture (n = 5893). Expression quantitative trait locus (eQTL) analyses of iliac crest biopsies were performed in 84 postmenopausal women, and murine osteoblast expression of genes implicated by eQTL or by proximity to vBMD-associated SNPs was examined. We identified significant vBMD associations with five loci, including: 1p36.12, containing WNT4 and ZBTB40; 8q24, containing TNFRSF11B; and 13q14, containing AKAP11 and TNFSF11. Two loci (5p13 and 1p36.12) also contained associations with radiographic and clinical vertebral fracture, respectively. In 5p13, rs2468531 (minor allele frequency [MAF] = 3%) was associated with higher vBMD (β = 0.22, p = 1.9 × 10-8 ) and decreased risk of radiographic vertebral fracture (odds ratio [OR] = 0.75; false discovery rate [FDR] p = 0.01). In 1p36.12, rs12742784 (MAF = 21%) was associated with higher vBMD (β = 0.09, p = 1.2 × 10-10 ) and decreased risk of clinical vertebral fracture (OR = 0.82; FDR p = 7.4 × 10-4 ). Both SNPs are noncoding and were associated with increased mRNA expression levels in human bone biopsies: rs2468531 with SLC1A3 (β = 0.28, FDR p = 0.01, involved in glutamate signaling and osteogenic response to mechanical loading) and rs12742784 with EPHB2 (β = 0.12, FDR p = 1.7 × 10-3 , functions in bone-related ephrin signaling). Both genes are expressed in murine osteoblasts. This is the first study to link SLC1A3 and EPHB2 to clinically relevant vertebral osteoporosis phenotypes. These results may help elucidate vertebral bone biology and novel approaches to reducing vertebral fracture incidence. © 2016 American Society for Bone and Mineral Research.